key: cord-0839883-la6wlz9d
authors: George, Shaji; Ansari, Mohammad Salahuddin; Kalliath, Anto; Khan, Mohammad Jawaid; Abdullah, Muhammad Syafiq; Asli, Rosmonaliza; Momin, Riamiza Natalie; Mani, Babu Ivan; Chong, Pui Lin; Chong, Vui Heng
title: COVID‐19 in children in Brunei Darussalam: Higher incidence but mild manifestations
date: 2020-07-27
journal: J Med Virol
DOI: 10.1002/jmv.26310
sha: 007b72a12863364063cdf7bbc6d53b83217ec1ba
doc_id: 839883
cord_uid: la6wlz9d

Brunei Darussalam documented its first pediatric (≤ 12 years) case of the novel Corona Virus Disease 2019 (COVID-19) on the 10th March 2020 and to date, there is a total of 12 confirmed cases. All were diagnosed through contact tracing of family members, typically fathers. All remained stable during their hospitalization. Most (75%) had mild symptoms and did not require specific treatment for COVID-19. The median length of hospitalization was 14 days (the duration of required isolation). In summary, we reported a higher incidence of COVID-19 in children, but with mild manifestations and no sequelae or complications on follow up. This article is protected by copyright. All rights reserved.

Dear Editor, Corona Virus Disease 2019 (COVID-19) predominately affects the adult population and it is estimated that children account for only between 2% and 5% of all COVID-19 cases. [1] [2] [3] The manifestations in children are usually mild but severe manifestations have been reported. Here we share our experience in pediatric patients with COVID-19.

In Brunei Darussalam, all reverse transcriptase-polymerase chain reaction (RT-PCR) confirmed COVID-19 cases were admitted to the National Isolation Centre for a minimum of 14 days. For the pediatric patients (≤12 years), we deviated slightly from our management protocol previously described, 4 with an initial clinical assessment to decide on the need for investigations. To minimize trauma, blood investigations were only done when indicated. Patients were monitored with the Paediatric Early Warning Score. Swabbing for RT-PCR was done on the 13th day of hospitalization as per protocol. If the test was positive, then this was repeated at 48 hours' intervals. A negative result was followed by a repeat in 24 hours. Once two consecutive negatives were obtained and with clinical symptoms recovery, patients were discharged. Postdischarge, patients were issued a 14 days' self-isolation notice and were also monitored. On the 11th day, a repeat RT-PCR was done, and patients were readmitted if they retested positive.

As of 15th June 2020, there was a total of 141 confirmed COVID-19 cases, of which 12 (8.5%) were in the pediatric population (median age 6 years [range: 6 months-12 years] and seven boys and five girls). Summary of patients' profiles, progress, and outcomes is shown in Table 1 . All were categorized as mild COVID-19. Four patients had comorbidities. All were diagnosed through contact tracing involving mostly family members who had traveled overseas. Overall 8 (66.7%) had mild symptoms, including one who developed symptoms after admission. Fever (50.0%) and cough (50.0%) were the most common symptoms. Only three (25%) had blood investigations. 6 All our patients had mild disease and did not require any specific treatment for COVID-19. As our understanding increases, management protocols will continue to evolve. Even though a less aggressive management approach can be adopted, we must remain vigilant, monitor closely and investigate appropriately not just during hospitalizations, but also after discharge as delayed immune driven complications such as Kawasaki like syndrome have been reported. 7, 8 In conclusion, we showed that the incidence of COVID-19 in children in Brunei Darussalam is higher than reported, and in agreement with what has been published in the literature, manifestations are generally mild.

The authors declare that there are no conflict of interests.

All authors involved with care of patients and contributed to data collections. SG and VHC conceived the idea. SG and VHC drafted the first draft. All authors critically review the manuscript. VHC revised the manuscript, all authors approved the final version. 

Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults

Coronavirus disease 2019 in children: characteristics, antimicrobial treatment, and outcomes

Clinical characteristics of COVID-19 infection in newborns and pediatrics: a systematic review

Conduction abnormalities in hydroxychloroquine add on therapy to lopinavir/ritonavir in COVID-19

Children with coronavirus disease 2019: a review of demographic, clinical, laboratory, and imaging features in pediatric patients

Higher prevalence of asymptomatic or mild COVID-19 in children, claims and clues

SARS-CoV-2-induced Kawasaki-like hyperinflammatory syndrome: a novel COVID phenotype in children

Cardiac dysfunction and thrombocytopenia-associated multiple organ failure inflammation phenotype in a severe paediatric case of COVID-19